Prolonged release of GM-CSF

Details Prolonged release of GM-CSF Prolonged release of GM-CSF

1998-11-03

2000-09-19

Azpuru, Carlos A.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Particulate form

424502, A61K 950

Patent

active

061208078

ABSTRACT:
Formulations for controlled, prolonged release of GM-CSF have been developed. These are based on solid microparticles formed of the combination of biodegradable, synthetic polymers such as poly(lactic acid) (PLA), poly(glycolic acid) (PGA), and copolymers thereof with excipients and drug loadings that yield zero order or first order release, or multiphasic release over a period of approximately three to twenty one days, preferably one week, when administered by injection. In the preferred embodiment, the microparticles are microspheres having diameters in the range of 10 to 60 microns, formed of a blend of PLGA having different molecular weights, most preferably 6,000, 30,000 and 41,000. Other embodiments hare been developed to alter the release kinetics or the manner in which the drug is distributed in vivo. For example, in some cases a polymer is selected which elicits a mild inflammatory reaction, for example, PLGA and polyanhydrides can act as chemoattractant, either due to the polymer itself or minor contaminants in the polymer, or polymers which are bioadhesive are used for transmucosal or oral delivery. In another embodiment, the GM-CSF is administered in a hydrogel which can be injected subcutaneous or at a specific site for controlled release. The microparticles or hydrogel are administered to the patient in an amount effect to stimulate proliferation of hematopoietic cells, especially white cells.

REFERENCES:
patent: 1995970 (1935-03-01), Dorough
patent: 2675945 (1954-04-01), Higgins
patent: 2683136 (1954-07-01), Higgins
patent: 2703316 (1955-03-01), Scneider
patent: 2758987 (1956-08-01), Salzberg et al.
patent: 2951828 (1960-09-01), Zeile
patent: 3523906 (1970-08-01), Vrancken
patent: 3531561 (1970-09-01), Trehu
patent: 3737337 (1973-06-01), Schnoring et al.
patent: 3773919 (1973-11-01), Boswell et al.
patent: 4272398 (1981-06-01), Jaffe
patent: 4542025 (1985-09-01), Tice et al.
patent: 4767628 (1988-08-01), Hutchinson et al.
patent: 4849228 (1989-07-01), Yamamoto et al.
patent: 4897268 (1990-01-01), Tice et al.
patent: 4962091 (1990-10-01), Eppstein et al.
patent: 5000886 (1991-03-01), Lawter et al.
patent: 5078996 (1992-01-01), Conlon et al.
patent: 5192741 (1993-03-01), Orsolini et al.
patent: 5229496 (1993-07-01), Deeley et al.
patent: 5286495 (1994-02-01), Hubbell et al.
patent: 5391485 (1995-02-01), Deeley et al.
patent: 5393870 (1995-02-01), Deeley et al.
patent: 5410016 (1995-04-01), Hubbell et al.
patent: 5416071 (1995-05-01), Igari et al.
patent: 5478564 (1995-12-01), Wantier et al.
Benita,et al, "Characterization of drug-loaded poly(d,l-lactide) microspheres," J Pharm Sci. 73(12):1721-4 (1984).
Braunstein, et al., "GM-CSF activates regenerative epidermal growth and stimulates keratinocyte proliferation in human skin in vivo," J Invest Dermatol. 103(4):601-4 (1994).
Grabstein, et al., "Regulation of antibody production in vitro by granulocyte-macrophage colony stimulating factor," J Mol Cell Immunol. 2(4):199-207 (1986).
Lim, et al., "Microencapsulation of Living Cells and Tissues," J. Pharm. Sci. 70: 351-354 (1981).
Lu, et al., :Protein Release from Poly(lactic-co-glycolic acid) Microspheres: Protein Stability Problems, J. Pharm. Sci. Technical 49:13-19 (1995).
Hongkee Sah, et al., "The Influence of Biodegradable Microcapsule Formulations of a Controlled Release of a Protein," J. Controlled Release 30:201-211 (1994).
Mathiowitz, et al, "Morphology of Polyanhydride Microsphere Delivery Systems," Scanning Microscopy 4:329-340 (1990).
Mathiowitz, et al., "Polyanhydride Microspheres as Drug Carriers I. Hot-Melt Microencapsulation," J. Controlled Release 5:13-22 (1987).
Mathiowitz, et al., "Polyanhydride Microspheres as Drug Carriers II. Microencapsulation by Solvent Removal," J. Appl. Polymer Sci.:35: 755-774 (1988).
Mathiowitz, et al., "Novel Microcapsules for Delivery Systems," Reactive Polymers 6:275-283 (1987).
Morrissey, et al., "Granulocyte-Macrophage Colony-Stimulation Factor Augments the Primary Antibody response By Enhancing the Function of Antigen-Presenting Cells," J. Immunology 139: 1113-1119 (1987).
Salib, et al., "Utilization of Sodium Alginate in Drug Microencapsulation," Pharmazeutische Industrie 40(11A): 1230-1234 (1978).

Affiliated with

Also associated with

Rating

Prolonged release of GM-CSF does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prolonged release of GM-CSF, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prolonged release of GM-CSF will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1069681